Duplicate price scheme proposed for exportable medicines

Published: 2013-08-14 06:56:00

Updated: 2013-08-14 06:56:00

The local research organization has recommended a “duplicate price” scheme in which the manufacturer of exportable drugs would refund to the National Health Insurance Corporation the price difference existing between the export price of a locally developed drug and its actual price covered by the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK